Medical devices, healthcare technology and the business of care
PMA approval · P250012

Simplera Sync Sensor, Guardian 4 Sensor

Medtronic MiniMed, Inc. · Decision date Aug 6, 2025

FDA DECISIONP250012

What did the FDA approve?

FDA records P250012 as an original PMA application. The recorded decision is approval, dated Aug 6, 2025.

FDA approval order statement

Approval of the Simplera Sync sensor and Guardian 4 sensor, intended to function as components of a Medtronic automated insulin dosing system.
Regulatory pathway
Original PMA
Clinical specialty
Clinical Chemistry
Decision date
Aug 6, 2025

FDA source record

Regulatory record facts

Identifier
P250012
Regulatory pathway
Premarket approval application
Product code
SFI
Decision code
APPR
Decision date
Aug 6, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Sensor, Glucose, Invasive, Component of automated insulin delivery system.

Product code
SFI
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P250012 received

    Application receipt date recorded by FDA.

  2. P250012 · FDA decision

    APPR

  3. P250012/S001 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  4. P250012/S003 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  5. P250012/S004 · Related supplement

    Simplera Sync Sensor, Guardian 4 Sensor

  6. P250012/S005 · Related supplement

    Simplera Sync Sensor; Guardian 4 Sensor

  7. P250012/S010 · Related supplement

    Simplera and Simplera Sync

Timeline entries are records held by MedtechLedger for P250012. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P250012

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic MiniMed, Inc.PMA supplementAug 25, 2025FDA
Medtronic MiniMed, Inc.PMA supplementSep 12, 2025FDA
Guardian 4 SensorP250012/S002
Medtronic MiniMed, Inc.PMA supplementOct 9, 2025FDA
Medtronic MiniMed, Inc.PMA supplementOct 16, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 5, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 8, 2025FDA
Medtronic MiniMed, Inc.PMA supplementDec 10, 2025FDA
Medtronic MiniMed, Inc.PMA supplementMar 19, 2026FDA
Medtronic MiniMed, Inc.PMA supplementMay 26, 2026FDA
Medtronic MiniMed, Inc.PMA supplementJun 12, 2026FDA
Simplera SyncP250012/S011
Medtronic MiniMed, Inc.PMA supplementJul 21, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic MiniMed, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
18000 Devonshire St., Northridge, CA, 91325

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records